HCA Healthcare, Inc. (HCA) — Financial statements
Income statement, balance sheet, and cash flow for HCA Healthcare, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 75,600↑7.1% | 70,603↑8.7% | 64,968↑7.9% | 60,233↑2.5% | 58,752 | |
| Cost of Revenue | 44,226↑5.5% | 41,925↑6.4% | 39,389↑6.3% | 37,056↑2.2% | 36,260 | |
| Gross Profit | 31,374↑9.4% | 28,678↑12.1% | 25,579↑10.4% | 23,177↑3.0% | 22,492 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 7,997↓74.3% | 31,170↑5.7% | 29,487↑6.5% | 27,685↑3.4% | 26,779 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 7,997↓74.3% | 31,170↑5.7% | 29,487↑6.5% | 27,685↑3.4% | 26,779 | |
| Other Expenses | 11,412↑187.5% | -13,039↑3.7% | -13,535↑0.2% | -13,561↑2.9% | -13,965 | |
| Operating Expenses | 19,409↑7.0% | 18,131↑13.7% | 15,952↑12.9% | 14,124↑10.2% | 12,814 | |
| Total Costs & Expenses | 63,635↑6.0% | 60,056↑8.5% | 55,341↑8.1% | 51,180↑4.3% | 49,074 | |
| Operating Results | ||||||
| Operating Income | 11,965↑13.4% | 10,547↑9.6% | 9,627↑6.3% | 9,053↓6.5% | 9,678 | |
| Depreciation & Amortization | 3,523↑6.4% | 3,312↑7.6% | 3,077↑3.6% | 2,969↑4.1% | 2,853 | |
| EBITDA | 15,603↑12.3% | 13,896↑9.2% | 12,721↓4.3% | 13,290↓6.7% | 14,252 | |
| EBIT | 12,080↑14.1% | 10,584↑9.7% | 9,644↓6.6% | 10,321↓9.5% | 11,399 | |
| Interest & Other Income | ||||||
| Net Interest Income | -2,248↓9.1% | -2,061↓6.3% | -1,938↓11.4% | -1,739↓13.7% | -1,529 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 2,248↑9.1% | 2,061↑6.3% | 1,938↑11.4% | 1,739↑13.7% | 1,529 | |
| Non-Operating Income | -115↓210.8% | -37↓117.6% | -17↑98.7% | -1,268↑26.3% | -1,721 | |
| Other Income / Expenses | -2,133↓5.4% | -2,024↓5.4% | -1,921↓306.1% | -473↓405.2% | 155 | |
| Income Before Tax | 9,832↑15.4% | 8,523↑10.6% | 7,706↓10.2% | 8,580↓12.7% | 9,833 | |
| Income Tax Expense | 2,050↑9.9% | 1,866↑15.5% | 1,615↓7.5% | 1,746↓17.3% | 2,112 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 7,782↑16.9% | 6,657↑9.3% | 6,091↓10.9% | 6,834↓11.5% | 7,721 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 6,784↑17.8% | 5,760↑9.9% | 5,242↓7.1% | 5,643↓18.9% | 6,956 | |
| Bottom-Line Net Income | 6,784↑17.8% | 5,760↑9.9% | 5,242↓7.1% | 5,643↓18.9% | 6,956 | |
| EPS (Basic) | 28.62↑28.5% | 22.27↑15.7% | 19.24↓1.0% | 19.44↓9.6% | 21.51 | |
| EPS (Diluted) | 28.38↑29.0% | 22.00↑16.0% | 18.96↓1.0% | 19.15↓9.5% | 21.16 | |
| Weighted Average Shares | 231↓10.8% | 259↓5.1% | 272↓6.2% | 290↓10.2% | 323 | |
| Weighted Average Diluted Shares | 231↓11.9% | 262↓5.3% | 276↓6.2% | 295↓10.4% | 329 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.